December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant

December 20, 2024

Long COVID Shows Five Distinct Patterns: Study

In the 2024 update, the NIH's RECOVER Initiative identified five distinct symptom patterns and new diagnostic thresholds for long COVID.

Conexiant

December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 18, 2024

Doctor Unions Surge Tenfold Since 2023

The number of physicians seeking to unionize has spiked in recent years.

Conexiant

December 17, 2024

AHA Updates Stroke Palliative Care Guidelines

Updated statement promotes integrated palliative care for all stroke patients.

Conexiant

December 16, 2024

Migraine Medicine May Help Gut Disorders

A genetic analysis published in Neurology Genetics revealed significant shared genetic connections between migraine and various gastrointestinal disorders, suggesting avenues for targeted treatment through the CGRP pathway.

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

December 16, 2024

New Four-Stage System Redefines AF Care

New atrial fibrillation management guidelines embrace a novel 4-stage classification system and early rhythm control strategy, with clinical trials showing a 21% reduction in cardiovascular outcomes when rhythm control is initiated within 12 months of diagnosis.

Conexiant

December 16, 2024

Childhood Smoking Exposure Affects MS Risk

New research reveals children with genetic risk for multiple sclerosis show elevated Epstein-Barr virus antibodies and reduced brain volumes when exposed to household smoking, suggesting environmental factors interact with genetic susceptibility years before typical MS onset.

Conexiant